ClinVar Miner

Submissions for variant NM_000426.4(LAMA2):c.922G>A (p.Glu308Lys)

gnomAD frequency: 0.00086  dbSNP: rs146462599
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000224668 SCV000281336 uncertain significance not provided 2015-05-29 criteria provided, single submitter clinical testing Converted during submission to Uncertain significance.
Illumina Laboratory Services, Illumina RCV000340277 SCV000459993 uncertain significance Congenital muscular dystrophy due to partial LAMA2 deficiency 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
GeneDx RCV000498838 SCV000589339 likely benign not specified 2018-02-27 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000529189 SCV000658803 benign LAMA2-related muscular dystrophy 2025-01-29 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000224668 SCV000842634 uncertain significance not provided 2018-06-22 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000224668 SCV001154868 likely benign not provided 2024-10-01 criteria provided, single submitter clinical testing LAMA2: BS2
Genetic Services Laboratory, University of Chicago RCV000498838 SCV002069798 uncertain significance not specified 2019-03-05 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV000224668 SCV002542222 uncertain significance not provided 2023-01-05 criteria provided, single submitter clinical testing BP4
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000224668 SCV001799233 uncertain significance not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000224668 SCV001972832 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.